Platelet Rich Plasma vs Minoxidil. Exploring effective treatments for Male pattern hair loss.

Management of Androgenic Alopecia by either Platelet Rich Plasma or Minoxidil.A CLINICAL TRIAL - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093644

Enrollment

Registered

2025-08-25

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Platelet Rich plasma: Four sessions of Platelet Rich plasma at regular intervals of two weeks. Intervention2: Nil: Nil Control Intervention1: Minoxidil: One ml of minoxidil spray Four

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with ANDROGENIC ALOPECIA based on NORWOOD SCALE. Patients categorised as ASA1 and ASA2 based on AMERICAN SOCIETY OF ANESTHESIOLOGIST. Patients who are willing to use minoxidil as part of treatment.

Exclusion criteria

Exclusion criteria: Hematological disorder patients. Malnourished patients. Thyroid disorder patients.

Design outcomes

Primary

Measure	Time frame
Numerical scale (0-10),0 indicates not satisfied and 10 indicates highly satisfied. 5 means average. Timepoint: The final evaluation will be conducted 12 weeks after the start of treatment.	—

Secondary

Measure	Time frame
Hair count noted at prefixed square area at each visit. Subjective improvement with score 1 to 10,worst(1) to best (10).Timepoint: 12 weeks after start of treatment.	—

Countries

India

Contacts

Public ContactDr Dheeraj Kumar

Kothiwal Dental College and Research Centre

gauravjournals107@gmail.com9736565635

Outcome results